- 28% confirmed response rate (5/18) per RECIST v1.1 in unselected patients across doses prioritized for expansion (7.2, 8.6 and 10 mg/kg Q3W) - - 3 of 7 evaluable patients (43%) with confirmed responses at upper expansion dose (10 mg/kg Q3W) - - Median …
The Electric Dream Machine Created a Cyborg Sand Sculpture, Futuristic Control Panel and Holographic Mascot Using 14 Epson Projectors and AI Generated Video and Graphics LOS ALAMITOS, Calif., May 12, 2025 /PRNewswire/ -- Over the past several years, the entrance to the South Florida …
Core & Main, Inc. (NYSE:CNM) saw a decent share price growth of 16% on the NYSE over the last few months. Shareholders may appreciate the recent price jump, but the company still has a way to go before reaching its yearly highs again. With …
Fresh produce company Dole (NYSE:DOLE) announced better-than-expected revenue in Q1 CY2025, but sales fell by 1% year on year to $2.10 billion. Its non-GAAP profit of $0.35 per share was 10.7% below analysts’ consensus estimates. Is now the time to buy Dole? Find out …
The U.S.-China truce trade is on, and the auto industry is center stage, thanks to its reliance on global production hubs and supply chains. Shares in Mercedes-Benz and BMW rose roughly 5% Monday. The cheaper SUVs they sell in China are manufactured locally. Continue …
Fulton Financial (NASDAQ:FULT) First Quarter 2025 Results Key Financial Results Revenue: US$304.5m (up 20% from 1Q 2024). Net income: US$90.4m (up 52% from 1Q 2024). Profit margin: 30% (up from 24% in 1Q 2024). The increase in margin was driven by higher revenue. EPS: …
Key Insights HEICO's estimated fair value is US$264 based on 2 Stage Free Cash Flow to Equity Current share price of US$264 suggests HEICO is potentially trading close to its fair value Our fair value estimate is 1.8% lower than HEICO's analyst price target …
Consumer products behemoth Proctor & Gamble (NYSE:PG) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 2.1% year on year to $19.78 billion. Its non-GAAP profit of $1.54 per share was 0.9% above analysts’ consensus estimates. Is now the time …
Beverage company Keurig Dr Pepper (NASDAQ:KDP) reported Q1 CY2025 results topping the market’s revenue expectations , with sales up 4.8% year on year to $3.64 billion. Its non-GAAP profit of $0.42 per share was 9.1% above analysts’ consensus estimates. Is now the time to …
Apogee Therapeutics Phase 2 APEX trial of APG777 in atopic dermatitis advancing with interim Part A 16-week data expected in mid-2025 and Part B actively enrolling First patient dosed in Phase 1b trial of APG777 in mild-to-moderate asthma with readout expected in 1H 2026 …